CALB2 and Miyoshi myopathy: Since the first evaluation of calretinin as an immunohistochemical marker of MM [13], several studies have demonstrated the significance of calretinin as a reliable marker for the diagnosis of MM, based on its high sensitivity (up to 100%) and specificity (up to 87.5%) in tumor tissues [14-17].